Regular NSAID Use May Improve Survival in Some with Head and Neck Cancer August 12, 2019 Regular nonsteroidal anti- inflammatory drugs use likely confers a statistically and clinically significant advantage disease-specific survival overall survival in patients with head and neck squamous cell carcinoma.